Systemic chemotherapy, such as a combination of cisplatin with 5-fluorouracil, carboplatin, or EGFR inhibitors, is typically employed as adjuvant therapy or for treating locally advanced, inoperable, or metastatic disease. This evidence concerns the gene EGFR and metastatic neoplasm.